Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Single Institution
100%
Postmenopausal Women
100%
Neoadjuvant Endocrine Therapy
100%
Tumor
28%
Clinical Response
28%
Hormone Receptor-positive Breast Cancer
28%
Response Rate
14%
Breast Cancer
14%
Radiation Therapy
14%
Tumor Size
14%
Surgical Outcomes
14%
Surgical Treatment
14%
Well-defined
14%
Adjuvant Radiotherapy
14%
Tumor Characteristics
14%
Adjuvant Chemotherapy
14%
Neoadjuvant
14%
Endocrine Therapy
14%
Estrogen Receptor-positive Breast Cancer
14%
Gonadotropin-releasing Hormone
14%
Systemic Treatment
14%
Descriptive Statistics
14%
Response Evaluation Criteria in Solid Tumors (RECIST)
14%
Patient Tumor
14%
Personalized Therapy
14%
Response-adapted
14%
Breast-conserving Therapy
14%
Positive Margins
14%
Downstaging
14%
Neoadjuvant Setting
14%
Aromatase Inhibitors
14%
Hormone Receptor-positive
14%
Premenopausal Patients
14%
Endocrine Response
14%
Systemic Intervention
14%
Medicine and Dentistry
Premenopause
100%
Hormone Therapy
100%
Neoplasm
50%
Postmenopause
50%
Breast Cancer
50%
Hormone Receptor
50%
Personalized Medicine
16%
Adjuvant Radiotherapy
16%
Adjuvant Chemotherapy
16%
Tamoxifen
16%
Endocrine Tumor
16%
Response Evaluation Criteria in Solid Tumors
16%
Estrogen Receptor Positive Breast Cancer
16%
Releasing Factor
16%
Aromatase Inhibitor
16%
Diseases
16%
Radiation Therapy
16%
Radiation Treatment
16%
Pharmacology, Toxicology and Pharmaceutical Science
Endocrine Therapy
100%
Neoplasm
50%
Breast Cancer
50%
Hormone Receptor
50%
Chemotherapy
16%
Solid Malignant Neoplasm
16%
Estrogen Receptor Positive Breast Cancer
16%
Endocrine Tumor
16%
Tamoxifen
16%
Aromatase Inhibitor
16%
Releasing Factor
16%
Diseases
16%